United States Market

USA Market

FDA Drug Establishment Registration & Renewal Services

Start Smart. Stay Compliant. Sell Confidently in the U.S. Market.

ENQUIRE NOW

    Why Is FDA Drug Establishment Registration & Renewal Services Important?

    Assurance

    Legal Requirement

    Mandatory for all companies manufacturing or processing drugs for U.S. distribution, including domestic and foreign establishments.

    Patient Safety

    Annual Renewal

    Registration must be renewed yearly between October 1 and December 31 to maintain compliance and market access.

    Compliance

    Non-Compliance Risks

    Failing to register or renew can result in penalties, product seizures at ports, and removal from FDA’s public database.

    Process Flow for FDA Drug Establishment Registration & Renewal Services

    process counter bg

    Identification

    DUNS numbers for facility and labeler

    process counter bg

    Representation

    U.S. Agent details for foreign companies

    process counter bg

    Product Details

    NDC, dosage form, route of administration

    process counter bg

    Labeling

    Packaging specifications for SPL submission

    process counter bg

    Declarations

    Compliance statements and manufacturing operations

    How Can We Help in FDA Drug Establishment Registration & Renewal Services?

    We-can-help-you-find

    Expertise You Can Count On: Our specialized regulatory team understands the nuances of FDA systems, SPL submissions, and complex labeling requirements for pharmaceutical products.

    We-Can-help

    Speed & Accuracy: Get your facility registered in as little as 5–7 business days, with zero submission errors and maximum efficiency.

    technical documentation

    Dedicated Support: One point of contact throughout your registration process. No ticket systems. Just answers when you need them most.

    We-can-assist

    Global Reach: We support both U.S.-based firms and international companies entering the American pharmaceutical market.

    help illustration Glow Icon

    Services

    Service Details
    Establishment Registration
    • Complete FDA facility registration for new manufacturing sites with expert guidance.
    Drug Product Listing
    • Comprehensive SPL submission services for all your pharmaceutical products.
    Annual Renewal
    • Timely filing to ensure continuous compliance with FDA requirements.
    U.S. Agent Services
    • Dedicated representation for foreign manufacturers entering the U.S. market.

    Regulatory Requirements for FDA Drug Establishment Registration & Renewal Services

    Documents

    Documents

    For Establishment Registration

    1. DUNS Number (Data Universal Numbering System – for both establishment and labeler)
    2. Business type and activity (e.g., manufacturer, relabeler, packager)
    3. Facility contact information
    4. U.S. Agent details (required for foreign entities)
    5. Electronic Submissions Gateway (ESG) account (or submission via SPL through a third-party provider)

    For Drug Listing

    1. NDC (National Drug Code) labeler code
    2. Product name, dosage form, strength, and route of administration
    3. Proprietary/Nonproprietary names
    4. Labeling content in Structured Product Labeling (SPL) XML format
    5. Marketing status (e.g., prescription, OTC, discontinued)
    Timeline

    Timeline

    Registration must be renewed annually between October 1 and December 31. If submitted within this period, the registration remains valid until the end of the following calendar year. 

    Initial Registration

    Must register within *5 days* of beginning manufacturing, repackaging, or relabeling activity for U.S. market

    Drug Listing

    Should occur *immediately after registration* and prior to commercial distribution

    Annual Renewal

    Required between *October 1 and December 31* of each calendar year

    Please Note: Registration does *not roll over*—renewal is mandatory each year to maintain active status in the FDA’s NDC Directory.

    Regulatory-Body

    Regulatory Body

    The U.S. Food and Drug Administration (FDA), specifically the Center for Drug Evaluation and Research (CDER), is the designated authority overseeing Drug Establishment Registration and Drug Listing requirements under the 

    Federal Food, Drug, and Cosmetic Act (FDCA) and 21 CFR Part 207.

    Fees

    Fees

    There is no FDA fee for Drug Establishment Registration Renewal for human drugs. However, other regulatory filings may have associated costs.

    If the establishment is also subject to GDUFA (Generic Drug User Fee Amendments), facility fees may apply separately depending on the type of drug/product and activity performed.

    ⚠ Be aware: Contract manufacturers, API manufacturers, and foreign establishments involved in generics may have annual user fees based on their GDUFA classification.

    Validity

    Validity

    Registration is valid from the date of submission until December 31 of the same calendar year. Establishments must renew registration annually to maintain their active status. If an establishment fails to renew by December 31, it will be considered inactive and removed from the FDA’s Establishment Registration database.

    Frequently Asked Questions(FAQs)

    Is registration mandatory for contract manufacturers or relabelers?​

    Yes. If you’re involved in the manufacture, repackaging, or labeling of any drug product for U.S. commerce, you must register.

    What if I miss the renewal deadline?

    Your registration becomes inactive, and your drug listings will be removed from the FDA’s NDC directory. This can disrupt your U.S. distribution.

    How long does registration take?​

    Usually 5–7 business days once we have complete and accurate information.​

    Do foreign companies need a U.S. Agent?​

    Yes. We can serve as your FDA-authorized U.S. Agent and handle all correspondence.​

    Send us your query on Regulatory Services in EU, USA and UK market

    HAVE A QUERY?
    REACH US!

    ENQUIRE NOW